Filing excerpt
On May 28, 2026, Medline Borrower, LP (the “Issuer”) and Medline Co-Issuer, Inc. (the “Co-Issuer” and, together with the Issuer, the “Issuers”), indirect subsidiaries of Medline Inc. (the “Company”), issued $1,250.0 million aggregate principal amount of 5.000% senior secured notes due 2031 (the “2031 Notes”) and $750.0 million aggregate principal amount of 5.250% senior secured notes due 2033 (the “2033 Notes” and, together with the 2031 notes, the “Notes”)